000 | 01638 a2200469 4500 | ||
---|---|---|---|
005 | 20250518071031.0 | ||
264 | 0 | _c20201023 | |
008 | 202010s 0 0 eng d | ||
022 | _a1471-2369 | ||
024 | 7 |
_a10.1186/s12882-019-1595-4 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aAthavale, Ambarish | |
245 | 0 | 0 |
_aDesmopressin and bleeding risk after percutaneous kidney biopsy. _h[electronic resource] |
260 |
_bBMC nephrology _c11 2019 |
||
300 |
_a413 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 |
_aAngiography _xmethods |
650 | 0 | 4 |
_aBiopsy _xadverse effects |
650 | 0 | 4 |
_aBlood Coagulation _xdrug effects |
650 | 0 | 4 |
_aCreatinine _xblood |
650 | 0 | 4 |
_aDeamino Arginine Vasopressin _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aHemostasis, Surgical _xstatistics & numerical data |
650 | 0 | 4 |
_aHemostatics _xadministration & dosage |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aKidney _xblood supply |
650 | 0 | 4 |
_aKidney Diseases _xdiagnosis |
650 | 0 | 4 | _aKidney Function Tests |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aOutcome and Process Assessment, Health Care |
650 | 0 | 4 | _aPatient Selection |
650 | 0 | 4 |
_aPostoperative Hemorrhage _xblood |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 |
_aUltrasonography _xmethods |
650 | 0 | 4 |
_aUnited States _xepidemiology |
700 | 1 | _aKulkarni, Hemant | |
700 | 1 | _aArslan, Cagil D | |
700 | 1 | _aHart, Peter | |
773 | 0 |
_tBMC nephrology _gvol. 20 _gno. 1 _gp. 413 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/s12882-019-1595-4 _zAvailable from publisher's website |
999 |
_c30316093 _d30316093 |